DRUG ACTION
1. Absorption 1. Distribution
• Route of • Plasma protein
administration binding
• Perfusion status • Lipid solubility
• GI motility Perfusion status
• Barriers (BBB,
placenta)
• Obesity
FACTORS AFFECTING
DRUG ACTION
1. Metabolism
• Age
• Drugs
• Liver disorders
6. Excretion
• Drug-drug interaction
• Blood concentration levels
• Renal status
NONNARCOTIC ANALGESICS
AND ANTIPYRETICS
• Levothyroxine
• Liothyronine
• Thyroglobulin (Proloid)
Adverse Effects:
• Signs of hyperthyroidism
THYROID HORMONES
Nursing Implications:
• Different brands of levothyroxine may not be
bioequivalent.
• Warn the patient (especially the elderly) to
tell the doctor if with signs of hyperthyroidism
• Instruct the patient to take thyroid hormones
at the same time each day to maintain
constant hormone levels.
• Medications taken in the morning.
• Monitor apical pulse and blood pressure. If
pulse is >100 bpm, withhold the drug.
• Store in air-tight and light-resistant
containers.
• Monitor prothrombin time; a patient taking
these hormones usually requires less
OXYTOCIN
Uses: Adverse Effects:
• Promotion of uterine • Hypotension
contractions • Tachycardia
• Control of bleeding • Water intoxication
• Release of milk from • Uterine rupture
breast
• Nausea and
Oxtocin-related
vomiting
drugs:
• Cardiovascular
• Methergine
collapse
• ergonovine
• Anaphylaxis
• Hypertension
(oxytocin-related
OXYTOCIN
Nursing Implications:
• Use infusion pump for administration.
Never give IM
• Monitor BP, heart rate and I and O.
• Regularly monitor for uterine
contractions and FHR.
• Discontinue if:
With note of tetanic uterine
contractions.
Signs of fetal distress
Urinary flow is less than 30 ml/hour
Signs of abruptio placenta and uterine
rupture
• For ergonovine/methergine- C/I for
patients with vascular, renal and
ANTIASTHMA DRUGS
• Beta adrenergic agonists
• Anticholinergic drugs
• Methylxanthines
• Mast Cell stabilizers
• Leukotriene inhibitors
• Cortocosteroids
Methylxanthines
• Theophylline Adverse Effects:
• Aminophylline • CNS stimulation
• Theo-dur • Tachycardia,
hypotension,
palpitations
Action:
• Nausea and vomiting
• Bronchodilator
• Rectal irritation
• CNS stimulant with suppository
• Increased renal
blood flow
Methylxanthines
Nursing Implications:
• Monitor theophylline levels.
• Monitor VS, I and O and symptoms of
toxicity
• Avoid smoking and use of marijuana.
• Administer with milk if with GI distress,
otherwise take before meals with water.
• Avoid excessive caffeine use
• Do not crush or chew time-release or
enteric coated tablets
Mast Cell Stabilizer
• Cromolyn sodium Adverse Effects:
• Nedocromil • Bronchoconstriction
• Cough
Actions: • Nasal congestion
• Prophylaxis against • rash
asthma attacks
• Allergic rhinitis
Mast Cell Stabilizer
Nursing Implications:
• Teach patient to use before exercising.
• Teach about proper use of inhaler
With spinhaler place capsule in container and exhale fully.
Place mouthpiece between lips.
Tilt head back and inhale fully.
Remove inhaler, Hold breath
Exhale slowly
• Rinse to reduce irritation in the mouth.
• Discontinue use if an allergic reaction
occurs.
ANTINEOPLASTIC AGENTS
• A. General Adverse Effects
• GI symptoms
• alopecia
• BM depression
• hepatotoxicity
• ↑ uric acid
• fatigue
• B. Prototype – Cyclophosphamide(Cytoxan)
• 1. Action. Produces cytoxic effects by damaging DNA
and interfering with cell replication.
• 2. Adverse Effects. Hemorrhagic and nonhemorrhagic
cystitis
• ANTIMETABOLITES
• Prototype – Methotrexate with leucovorin rescue
– 5-Fluorouracil (5-FU)
– Mercaptopurine (Purinethol)
– Cytarabine (Cytosar-U)
• Action. Leucovorin calcium is a folic acid analog that
interferes with mitotic process by blocking folinic acid.
• ANTIBIOTIC ANTINEOPLASTIC AGENTS
– Prototype – Dactinomycin and Doxorubicin HCl (Adriamycin)
• Action. Attaches to DNA and prevents DNA synthesis in vulnerable cells.
• Adverse Effects.
– hyperuricemia
– cardiotoxic
– BM depression
• VINCA ALKALOIDS
• Prototype – Vincristine (Oncovin) and Vinblastine
– Action. Acts on cells undergoing mitosis, thus stopping cell division.
– Adverse Effects. Neuropathy and neurotoxic
• MISCELLANEOUS ANTINEOPLASTIC AGENTS
• L-Asparaginase (Elspar)
– Action. Enzyme that destroys asparagines, an amino acid necessary for protein synthesis of
leukemia cells.
– Adverse Effects. Azotemia, hemorrhagic pancreatitis, hyperglycemia, hepatotoxicity
• Hydroxyurea (Hydrea)
– Action. Urea derivative that kills granulocytes